Unijules Injectable Private Limited - Company Profile

It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2020.
2020 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Unijules Injectable Private Limited

Unijules Injectable Private Limited, a active private limited company, was established on 03 July 2020 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24299MH2020PTC341380. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sanjay Kukreja Cheturam (Director), Ravindra Kanhaiyalal Kukreja (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 106-A, Medicine Market, Gandhi Bagh, Central Avenue Road,, Nagpur, Maharashtra, 440018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299MH2020PTC341380

  • Registration Number

    341380

  • Incorporation Date

    03 July 2020

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Unijules Injectable Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unijules Injectable Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Unijules Injectable Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjay Kukreja Cheturam Director 03 Jul 2020 Current
Ravindra Kanhaiyalal Kukreja Director 03 Jul 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unijules Injectable.

Enhance accessibility to Unijules Injectable's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Unijules Injectable revenue growth over time
Unijules Injectable profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unijules Injectable?

Unlock access to Unijules Injectable's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Unijules Injectable?

Unijules Injectable has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unijules Injectable, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unijules Injectable's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unijules Injectable
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Unijules Injectable Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Unijules Injectable Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Sanjay Kukreja Cheturam was appointed as a Director was appointed as a Director on 03 Jul 2020 & has been associated with this company since 5 years 7 months . was documented.

  • Director Appointment

    Ravindra Kanhaiyalal Kukreja was appointed as a Director was appointed as a Director on 03 Jul 2020 & has been associated with this company since 5 years 7 months . was recorded as a recent event.

  • Company Incorporation

    The activity Unijules Injectable Private Limited was registered on 03 Jul 2020 with Roc Mumbai & aged 5 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unijules Injectable Private Limited?

The CIN of Unijules Injectable Private Limited is U24299MH2020PTC341380.

Where is Unijules Injectable Private Limited headquartered?

Unijules Injectable Private Limited is headquartered at 106-A, Medicine Market, Gandhi Bagh, Central Avenue Road,, Nagpur, Maharashtra, 440018.

When was Unijules Injectable Private Limited incorporated?

Unijules Injectable Private Limited was incorporated on 03 July 2020.

Who are the current directors of Unijules Injectable Private Limited?

The current directors of Unijules Injectable Private Limited are

What is the primary industry of Unijules Injectable Private Limited?

The primary industry of Unijules Injectable Private Limited is Pharma.

Is Unijules Injectable Private Limited a listed company?

Unijules Injectable Private Limited is unlisted.

What is the capital structure of Unijules Injectable Private Limited?

The authorized capital of Unijules Injectable Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available